Search

Byline: Gireesh Babu The Department of Biotechnology (DBT) has invited researchers, scientists and clinicians to collaborate in multicentric projects to study consequences of viral infection including post Covid-19 impact on [...]

Castle Biosciences, Inc., a company improving health through innovative tests that guide patient care, announced new data supporting the clinical utility of its DecisionDx-Melanoma and DecisionDx-SCC tests in guiding risk-aligned [...]

A phase 1 trial testing the safety of an experimental nasal vaccine that may provide enhanced breadth of protection against emerging variants of SARS-CoV-2, the virus that causes Covid-19, is [...]

Byline: admin During the interaction, Dr. Solomon and Cloherty revealed that their ongoing focus is to expand our network globally and enhance capacity across all regions. Human Immunodeficiency Virus (HIV) [...]

Byline: Nandita Vijayasimha To thwart TB drug resistance and its medicine shortage, a 3D hydrogel culture system, designed at the Department of Bioengineering (BE), Indian Institute of Science (IISc), is [...]

Azura Ophthalmics Ltd, a clinical-stage biopharmaceutical company developing a potential new therapeutic class of Ophthalmic Keratolytics for ocular surface diseases, announced that the first patient has been enrolled in the [...]

An NIHR and UK Research and Innovation (UKRI) funded study has revealed that long Covid leads to ongoing inflammation which can be detected in blood. This suggests that existing drugs [...]

SARS-CoV-2, the virus that causes Covid-19, can damage the heart even without directly infecting the heart tissue, a National Institutes of Health-supported study has found. The research, published in the [...]

Byline: Shardul Nautiyal The Indian Council of Medical Research (ICMR) has recently unveiled a series of ground-breaking guidelines and policies aimed at bolstering healthcare efforts across various domains. From enhancing [...]

Osivax, a biopharmaceutical company developing vaccines to provide broad-spectrum protection against highly mutating infectious viruses, announced that the first participant has been vaccinated in its new phase 1 trial (NCT06128382) [...]

Byline: Shardul Nautiyal In a significant move towards advancing medical research and addressing key health challenges in the country, the Indian Council of Medical Research (ICMR) has launched the National [...]

Senhwa Biosciences, Inc., a drug development company focusing on first-in-class therapeutics for oncology, rare diseases, and infectious diseases, announced that Taiwan Food and Drug Administration has approved its phase II [...]

Cerecin Inc., a clinical-stage biotechnology company at the forefront of developing innovative neurotherapeutics, announced the establishment of a Memorandum of Understanding (MoU) with A*STAR's Institute of Molecular and Cell Biology [...]

Byline: Nandita Vijayasimha The National Institute of Mental Health and Neuro Sciences (NIMHANS) in partnership with the University of Liverpool along with a £1.5 million fund support from Pratiksha Trust, [...]

Gilead Sciences, Inc. announced PURPOSE 5, the first phase 2 clinical trial to evaluate an investigational long-acting HIV prevention option in Europe. The study will assess the persistence--defined as consistent [...]

Venatorx Pharmaceuticals, a private, pre-commercial pharmaceutical company focused on improving health outcomes for patients with multidrug-resistant bacterial infections and hard-to-treat viral infections, announced the Biomedical Advanced Research and Development Authority [...]

Byline: Our Bureau Alkem Laboratories and Biosergen AB have inked a co-development and license agreement for BSG005, an innovative polyene macrolide, through phase II and phase III trials for sale [...]

Byline: Just Earth News A recent study has found that unhealthy snacking habit is associated with metabolic diseases such as stroke, cardiovascular disease and obesity. The findings, published recently in [...]

In a new study, National Institutes of Health (NIH) researchers found that altered B cell function in children with mitochondrial disorders led to a weaker and less diverse antibody response [...]

Shionogi & Co., Ltd. announced the first patient has been enrolled in its phase 3 study in Japanese paediatric patients. The study will evaluate the pharmacokinetics, safety and tolerability of [...]

Byline: Shardul Nautiyal The Indian Council of Medical Research (ICMR) has invited Expression of Interest (EOI) for the Multistate Implementation Research Project on the integration of screening and treatment of [...]

Byline: Florham Park Celularity Inc. (Celularity), a biotechnology company developing placental-derived allogeneic cell therapies and biomaterial products, announced results from an exploratory analysis of phase 1 data evaluating alterations in [...]

Twelve people with persistent neurological symptoms after SARS-CoV-2 infection were intensely studied at the National Institutes of Health (NIH) and were found to have differences in their immune cell profiles [...]

Children with multisystem inflammatory syndrome (MIS-C) -- a rare condition linked with the virus that causes Covid-19 -- have biochemical indicators of cell injury and cell death that are distinct [...]

ContraFect Corporation, a clinical-stage biotechnology company, announced the initiation of a phase 1b/2 of exebacase in the setting of an arthroscopic debridement, antibiotics, irrigation, and retention (DAIR) procedure in patients [...]

The magnitude and quality of a key immune cell's response to vaccination with two doses of the Pfizer-BioNTech Covid-19 vaccine were considerably lower in people with prior SARS-CoV-2 infection compared [...]

Byline: admin KRIVIDA TRIVUS developed by Chennai-based KRIYA Medical technologies has received approval from ICMR (Indian Council of Medical Research). The RT-qPCR kit can detect the presence or absence of [...]

Byline: Just Earth News Edmonton: It may be better to let a mild fever run its course instead of automatically reaching for medication, new University of Alberta research suggests. Researchers [...]